Comprehensive Dermatologic Drug Therapy 2021
DOI: 10.1016/b978-0-323-61211-1.00036-x
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous Immunoglobulin Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 147 publications
0
1
0
Order By: Relevance
“…We theorize that IVIG may have accelerated catabolism of ETN via saturation of the neonatal Fc receptor and neutralized ETN via anti-idiotypic antibodies that could bind to the Fc portion of ETN. 19 22 Peak level of ETN occurs 2 days after injection. 22 ETN is given after IVIG for resistant Kawasaki disease at doses of 0.8 mg/kg SC within 24 h then repeated at days 7 and 14 which was the dosing we adopted for our patient’s second dose.…”
Section: Discussionmentioning
confidence: 99%
“…We theorize that IVIG may have accelerated catabolism of ETN via saturation of the neonatal Fc receptor and neutralized ETN via anti-idiotypic antibodies that could bind to the Fc portion of ETN. 19 22 Peak level of ETN occurs 2 days after injection. 22 ETN is given after IVIG for resistant Kawasaki disease at doses of 0.8 mg/kg SC within 24 h then repeated at days 7 and 14 which was the dosing we adopted for our patient’s second dose.…”
Section: Discussionmentioning
confidence: 99%